Global Liquid Biopsy Market - - Industry Trends and Forecast to 2031

List of Tables

The global liquid biopsy market is expected to reach USD 7,429.32 million by 2031 from USD 2,309.91 million in 2023, growing at a CAGR of 16.8% during the forecast period of 2024 to 2031.

Market Segmentation

Global Liquid Biopsy Market, By Product (Instruments, Consumables & Accessories, and Services & Software), Biomarker Type (Circulating Tumor Cells (CTCS), Circulating Cell-Free DNA (CFDNA), Cell-free RNA, Extracellular Vesicles, Exosomes, and Others), Sample Type (Blood Sample Based, Urine Sample Based, Saliva & Other Tissue Fluid Sample-Based, Fecal Based Sampling, and Others), Analytical Type (Molecular, Proteomics, and Histology/Imaging), Application Type (Cancer Applications and Non-Cancer Applications), Clinical Application (Routine Screening, Patient Work-Up, Therapy Selection, Treatment Monitoring, Recurrence Monitoring, and Others), Technology (Multi-Gene Parallel Analysis, and Single-Gene Analysis), End User (Hospitals, Reference Laboratories, Diagnostic Centers, Research Centers & Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributor, and Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2031.

Overview of Global Liquid Biopsy Market Dynamics

Driver
Growing demand for non-invasive liquid biopsy technique
Restraint
High cost of liquid biopsy test
Opportunity
Integration of artificial intelligence (AI) and machine learning

Market Players

Some of the major market players operating in the global liquid biopsy market are:

Thermo Fisher Scientific Inc.
Illumina, Inc.
BIOCEPT, INC.
Bio-Rad Laboratories, Inc.
Exact Science Corporation
Menarini Silicon Biosystems
Epic Sciences
NeoGenomics Laboratories
mdxhealth
F. Hoffmann-La Roche Ltd
QIAGEN
Oncocyte Corporation
Johnson & Johnson Services, Inc.
PathAI
Fluxion Biosciences Inc.
Guardant Health
Laboratory Corporation of America Holdings
ANGLE plc
Natera, Inc.
Sysmex Inostics Inc., (Subsidiary of Sysmex Corporation)
STRECK
Predicine

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL LIQUID BIOPSY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 MARKET TESTING TYPE COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS
4.2 PORTER FIVE FORCES MODEL

5 GLOBAL LIQUID BIOPSY MARKET, REGULATION

5.1 REGULATION IN THE U.S.
5.2 REGULATION IN THE CANADA

5.3 REGULATION IN EUROPE:

5.4 REGULATIONS IN CHINA:

5.5 REGULATIONS IN JAPAN:

5.6 REGULATIONS IN INDIA:

5.7 REGULATIONS IN CANADA:

5.8 REGULATIONS IN AUSTRALIA:

5.9 REGULATIONS IN SOUTH AFRICA:

5.10 REGULATIONS IN SAUDI ARABIA:

6 MARKET OVERVIEW

6.1 DRIVERS
- 6.1.1 GROWING DEMAND FOR NON-INVASIVE LIQUID BIOPSY TECHNIQUE
- 6.1.2 ADVANCEMENTS IN PRECISION MEDICINE DUE TO LIQUID BIOPSY
- 6.1.3 INCREASING CANCER PREVALENCE AND AWARENESS
- 6.1.4 TECHNOLOGICAL ADVANCEMENTS IN LIQUID BIOPSY PLATFORMS
6.2 RESTRAINTS
- 6.2.1 HIGH COST OF LIQUID BIOPSY TESTS
- 6.2.2 LACK OF STANDARDIZED GUIDELINES
6.3 OPPORTUNITIES
- 6.3.1 INTEGRATION OF ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING
- 6.3.2 INCREASING REIMBURSEMENTS AND GOVERNMENT SUPPORT FOR LIQUID BIOPSY
- 6.3.3 INCREASING R&D ACTIVITIES BY INSTITUTES
6.4 CHALLENGES
- 6.4.1 LACK OF SKILLED PROFESSIONALS PERFORMING LIQUID BIOPSY
- 6.4.2 INCREASED DEPENDENCY ON OTHER BIOPSIES

7 GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT

7.1 OVERVIEW
7.2 CONSUMABLES & ACCESSORIES
- 7.2.1 TEST KITS
  - 7.2.1.1 TOTAL NUCLEIC ACID ISOLATION KIT
  - 7.2.1.2 DNA ISOLATION KIT
  - 7.2.1.3 OTHERS
- 7.2.2 COLLECTION TUBES
  - 7.2.2.1 PIECES
  - 7.2.2.2 PIECES
- 7.2.3 ASSAYS
  - 7.2.3.1 FLEXIBLE REAGENTS
  - 7.2.3.2 SCALABLE REAGENTS
  - 7.2.3.3 OTHERS
- 7.2.4 CONTROL KIT
- 7.2.5 OTHERS
7.3 INSTRUMENTS
- 7.3.1 ANALYZERS
- 7.3.2 SYSTEMS
- 7.3.3 OTHERS
7.4 SERVICES & SOFTWARE
- 7.4.1 NGS ANALYSIS AND REPORTING SOFTWARE
- 7.4.2 DPCR ANALYSIS SOFTWARE
- 7.4.3 CASTPCR ANALYSIS SOFTWARE
- 7.4.4 OTHERS

8 GLOBAL LIQUID BIOPSY MARKET, BY BIOMAKER TYPE

8.1 OVERVIEW
8.2 CIRCULATING TUMOR CELLS (CTC'S)
- 8.2.1 CONSUMABLES & ACCESSORIES
- 8.2.2 INSTRUMENTS
- 8.2.3 SERVICES & SOFTWARE
8.3 CIRCULATING CELL-FREE DNA (CFDNA)
- 8.3.1 CONSUMABLES & ACCESSORIES
- 8.3.2 INSTRUMENTS
- 8.3.3 SERVICES & SOFTWARE
8.4 CELL-FREE RNA
- 8.4.1 CONSUMABLES & ACCESSORIES
- 8.4.2 INSTRUMENTS
- 8.4.3 SERVICES & SOFTWARE
8.5 EXOSOMES
- 8.5.1 CONSUMABLES & ACCESSORIES
- 8.5.2 INSTRUMENTS
- 8.5.3 SERVICES & SOFTWARE
8.6 EXTRACELLULAR VESICLES
- 8.6.1 CONSUMABLES & ACCESSORIES
- 8.6.2 INSTRUMENTS
- 8.6.3 SERVICES & SOFTWARE
8.7 OTHERS

9 GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE TYPE

9.1 OVERVIEW
9.2 BLOOD SAMPLE-BASED
9.3 URINE SAMPLE-BASED
9.4 SALIVA & OTHER TISSUE FLUIDS SAMPLE-BASED
9.5 FECAL SAMPLE BASED
9.6 OTHERS

10 GLOBAL LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE

10.1 OVERVIEW
10.2 MOLECULAR
- 10.2.1 NGS
- 10.2.2 PCR
- 10.2.3 MICROARRAY
- 10.2.4 PROTEOMICS
- 10.2.5 OTHERS
10.3 PROTEOMIC
- 10.3.1 NGS
- 10.3.2 PCR
- 10.3.3 MICROARRAY
- 10.3.4 PROTEOMICS
- 10.3.5 OTHERS
10.4 HISTOLOGY/IMAGING

11 GLOBAL LIQUID BIOPSY MARKET, BY APPLICATION TYPE

11.1 OVERVIEW
11.2 CANCER APPLICATIONS
- 11.2.1 LUNG
- 11.2.2 BREAST
  - 11.2.2.1 EARLY BREAST CANCER
  - 11.2.2.1 ADVANCED BREAST CANCER
- 11.2.3 COLORECTAL
- 11.2.4 PROSTRATE
- 11.2.5 LIVER
- 11.2.6 OTHERS
11.3 NON-CANCER APPLICATIONS
- 11.3.1 PRENATAL DIAGNOSIS
- 11.3.2 PERSONALIZED IMMUNOTHERAPY
- 11.3.3 OTHERS

12 GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION

12.1 OVERVIEW
12.2 ROUTINE SCREENING
12.3 THERAPY SELECTION
12.4 TREATMENT MONITORING
- 12.4.1 EARLY-STAGE DISEASE
- 12.4.2 LATE-STAGE/METASTATIC DISEASE
12.5 RECURRENCE MONITORING
12.6 PATIENT WORK-UP
12.7 OTHERS

13 GLOBAL LIQUID BIOPSY MARKET, BY TECHNOLOGY

13.1 OVERVIEW
13.2 MULTI-GENE-PARALLEL ANALYSIS
13.3 SINGLE GENE ANALYSIS

14 GLOBAL LIQUID BIOPSY MARKET, BY END USER

14.1 OVERVIEW
14.2 HOSPITALS
14.3 REFERENCE LABORATORIES
14.4 DIAGNOSTIC CENTERS
14.5 RESEARCH CENTERS AND ACADEMIC INSTITUTES
14.6 OTHERS

15 GLOBAL LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW
15.2 DIRECT TENDER
15.3 THIRD PARTY DISTRIBUTOR
15.4 OTHERS

16 GLOBAL LIQUID BIOPSY MARKET, BY REGION

16.1 OVERVIEW
16.2 NORTH AMERICA
- 16.2.1 U.S.
- 16.2.2 CANADA
- 16.2.3 MEXICO
16.3 EUROPE
- 16.3.1 GERMANY
- 16.3.2 FRANCE
- 16.3.3 U.K.
- 16.3.4 ITALY
- 16.3.5 SPAIN
- 16.3.6 RUSSIA
- 16.3.7 TURKEY
- 16.3.8 BELGIUM
- 16.3.9 NETHERLANDS
- 16.3.10 SWITZERLAND
- 16.3.11 REST OF EUROPE
16.4 ASIA-PACIFIC
- 16.4.1 JAPAN
- 16.4.2 CHINA
- 16.4.3 SOUTH KOREA
- 16.4.4 INDIA
- 16.4.5 AUSTRALIA
- 16.4.6 SINGAPORE
- 16.4.7 THAILAND
- 16.4.8 MALAYSIA
- 16.4.9 INDONESIA
- 16.4.10 PHILIPPINES
- 16.4.11 REST OF ASIA-PACIFIC
16.5 SOUTH AMERICA
- 16.5.1 BRAZIL
- 16.5.2 ARGENTINA
- 16.5.3 REST OF SOUTH AMERICA
16.6 MIDDLE EAST AND AFRICA
- 16.6.1 SOUTH AFRICA
- 16.6.2 SAUDI ARABIA
- 16.6.3 U.A.E.
- 16.6.4 EGYPT
- 16.6.5 ISRAEL
- 16.6.6 REST OF MIDDLE EAST AND AFRICA

17 GLOBAL LIQUID BIOPSY MARKET, COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: GLOBAL

18 NORTH AMERICA LIQUID BIOPSY MARKET, COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

19 EUROPE LIQUID BIOPSY MARKET, COMPANY LANDSCAPE

19.1 COMPANY SHARE ANALYSIS: EUROPE

20 ASIA-PACIFIC LIQUID BIOPSY MARKET, COMPANY LANDSCAPE

20.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

21 COMPANY SHARE ANALYSIS BY PRODUCT

22 SWOT ANALYSIS

23 COMPANY PROFILE

23.1 F. HOFFMANN-LA ROCHE LTD
- 23.1.1 COMPANY SNAPSHOT
- 23.1.2 REVENUE ANALYSIS
- 23.1.3 COMPANY SHARE ANALYSIS
- 23.1.4 PRODUCT PORTFOLIO
- 23.1.5 RECENT DEVELOPMENT
23.2 GUARDANT HEALTH
- 23.2.1 COMPANY SNAPSHOT
- 23.2.2 REVENUE ANALYSIS
- 23.2.3 COMPANY SHARE ANALYSIS
- 23.2.4 PRODUCT PORTFOLIO
- 23.2.5 RECENT DEVELOPMENT
23.3 EXACT SCIENCES CORPORATION
- 23.3.1 COMPANY SNAPSHOT
- 23.3.2 REVENUE ANALYSIS
- 23.3.3 COMPANY SHARE ANALYSIS
- 23.3.4 PRODUCT PORTFOLIO
- 23.3.5 RECENT DEVELOPMENT
23.4 QIAGEN
- 23.4.1 COMPANY SNAPSHOT
- 23.4.2 REVENUE ANALYSIS
- 23.4.3 COMPANY SHARE ANALYSIS
- 23.4.4 PRODUCT PORTFOLIO
- 23.4.5 RECENT DEVELOPMENT
23.5 THERMO FISHER SCIENTIFIC INC.
- 23.5.1 COMPANY SNAPSHOT
- 23.5.2 REVENUE ANALYSIS
- 23.5.3 COMPANY SHARE ANALYSIS
- 23.5.4 PRODUCT PORTFOLIO
- 23.5.5 RECENT DEVELOPMENTS
23.6 ANGLE PLC (2022)
- 23.6.1 COMPANY SNAPSHOT
- 23.6.2 REVENUE ANALYSIS
- 23.6.3 PRODUCT PORTFOLIO
- 23.6.4 RECENT DEVELOPMENT
23.7 BIOCEPT, INC.
- 23.7.1 COMPANY SNAPSHOT
- 23.7.2 REVENUE ANALYSIS
- 23.7.3 PRODUCT PORTFOLIO
- 23.7.4 RECENT DEVELOPMENT
23.8 BIO-RAD LABORATORIES, INC. (2022)
- 23.8.1 COMPANY SNAPSHOT
- 23.8.2 REVENUE ANALYSIS
- 23.8.3 PRODUCT PORTFOLIO
- 23.8.4 RECENT DEVELOPMENT
23.9 EPIC SCIENCES
- 23.9.1 COMPANY SNAPSHOT
- 23.9.2 PRODUCT PORTFOLIO
- 23.9.3 RECENT DEVELOPMENT
23.10 FLUXION BIOSCIENCES INC
- 23.10.1 COMPANY SNAPSHOT
- 23.10.2 PRODUCT PORTFOLIO
- 23.10.3 RECENT DEVELOPMENT
23.11 ILLUMINA, INC.
- 23.11.1 COMPANY SNAPSHOT
- 23.11.2 REVENUE ANALYSIS
- 23.11.3 PRODUCT PORTFOLIO
- 23.11.4 RECENT DEVELOPMENTS
23.12 LABORATORY CORPORATION OF AMERICA HOLDINGS
- 23.12.1 COMPANY SNAPSHOT
- 23.12.2 REVENUE ANALYSIS
- 23.12.3 PRODUCT PORTFOLIO
- 23.12.4 RECENT DEVELOPMENT
23.13 MDXHEALTH
- 23.13.1 COMPANY SNAPSHOT
- 23.13.2 REVENUE ANALYSIS
- 23.13.3 PRODUCT PORTFOLIO
- 23.13.4 RECENT DEVELOPMENT
23.14 MENARINI SILICON BIOSYSTEMS
- 23.14.1 COMPANY SNAPSHOT
- 23.14.2 PRODUCT PORTFOLIO
- 23.14.3 RECENT DEVELOPMENT
23.15 NATERA, INC.
- 23.15.1 COMPANY SNAPSHOT
- 23.15.2 REVENUE ANALYSIS
- 23.15.3 PRODUCT PORTFOLIO
- 23.15.4 RECENT DEVELOPMENT
23.16 NEOGENOMICS LABORATORIES
- 23.16.1 COMPANY SNAPSHOT
- 23.16.2 REVENUE ANALYSIS
- 23.16.3 PRODUCT PORTFOLIO
- 23.16.4 RECENT DEVELOPMENT
23.17 ONCOCYTE CORPORATION
- 23.17.1 COMPANY PROFILE
- 23.17.2 SERVICE PORTFOLIO
- 23.17.3 RECENT DEVELOPMENT
23.18 PATHAI
- 23.18.1 COMPANY SNAPSHOT
- 23.18.2 PRODUCT PORTFOLIO
- 23.18.3 RECENT DEVELOPMENT
23.19 PREDICINE
- 23.19.1 COMPANY SNAPSHOT
- 23.19.2 PRODUCT PORTFOLIO
- 23.19.3 RECENT DEVELOPMENT
23.20 STRECK
- 23.20.1 COMPANY SNAPSHOT
- 23.20.2 PRODUCT PORTFOLIO
- 23.20.3 RECENT DEVELOPMENTS
23.21 SYSMEX INOSTICS INC. (SUBSIDIARY OF SYSMEX CORPORATION)
- 23.21.1 COMPANY SNAPSHOT
- 23.21.2 REVENUE ANALYSIS OF PARENT COMPANY
- 23.21.3 PRODUCT PORTFOLIO
- 23.21.4 RECENT DEVELOPMENT

24 QUESTIONNAIRE

25 RELATED REPORTS

LIST OF TABLES

TABLE 1 WAYS IN WHICH LIQUID BIOPSY HAS ADVANCED PRECISION MEDICINE
TABLE 2 GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 3 GLOBAL CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 4 GLOBAL CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 5 GLOBAL CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 6 GLOBAL TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 7 GLOBAL TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 8 GLOBAL COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 9 GLOBAL COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 10 GLOBAL ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 11 GLOBAL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 GLOBAL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 13 GLOBAL INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 14 GLOBAL SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 15 GLOBAL SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 16 GLOBAL LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 17 GLOBAL CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 18 GLOBAL CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 19 GLOBAL CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 GLOBAL CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 21 GLOBAL CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 GLOBAL CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 23 GLOBAL EXOSOMES IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 24 GLOBAL EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 25 GLOBAL EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 26 GLOBAL EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 27 GLOBAL OTHERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 28 GLOBAL LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 29 GLOBAL BLOOD SAMPLE-BASED IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 30 GLOBAL URINE SAMPLE-BASED IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 31 GLOBAL SALIVA & OTHER TISSUE FLUIDS SAMPLE-BASED IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 GLOBAL FECAL SAMPLE BASED IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 33 GLOBAL OTHERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 34 GLOBAL LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 35 GLOBAL MOLECULAR IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 36 GLOBAL MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 37 GLOBAL PROTEOMIC IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 38 GLOBAL PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 39 GLOBAL HISTOLOGY/IMAGING IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 40 GLOBAL LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 41 GLOBAL CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 42 GLOBAL CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 43 GLOBAL BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 44 GLOBAL NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 45 GLOBAL NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 46 GLOBAL LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 47 GLOBAL ROUTINE SCREENING IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 48 GLOBAL THERAPY SELECTION IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 49 GLOBAL TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 50 GLOBAL TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 51 GLOBAL RECURRENCE MONITORING IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 52 GLOBAL PATIENT WORK-UP IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 53 GLOBAL OTHERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 54 GLOBAL LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 55 GLOBAL MULTI-GENE-PARALLEL ANALYSIS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 56 GLOBAL SINGLE GENE ANALYSIS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 57 GLOBAL LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 58 GLOBAL HOSPITALS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 59 GLOBAL REFERENCE LABORATORIES IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 60 GLOBAL DIAGNOSTICS CENTERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 61 GLOBAL RESEARCH CENTRES AND ACADEMIC INSTITUTES IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 62 GLOBAL OTHERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 63 GLOBAL LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 64 GLOBAL DIRECT TENDER IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 65 GLOBAL THIRD PARTY DISTRIBUTOR IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 66 GLOBAL OTHERS IN LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 67 GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 68 NORTH AMERICA LIQUID BIOPSY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 69 NORTH AMERICA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 70 NORTH AMERICA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 71 NORTH AMERICA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 72 NORTH AMERICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 73 NORTH AMERICA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 74 NORTH AMERICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 75 NORTH AMERICA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 76 NORTH AMERICA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 77 NORTH AMERICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 78 NORTH AMERICA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 79 NORTH AMERICA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 80 NORTH AMERICA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 81 NORTH AMERICA CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 82 NORTH AMERICA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 83 NORTH AMERICA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 84 NORTH AMERICA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 85 NORTH AMERICA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 86 NORTH AMERICA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 87 NORTH AMERICA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 88 NORTH AMERICA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 89 NORTH AMERICA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 90 NORTH AMERICA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 91 NORTH AMERICA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 92 NORTH AMERICA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 93 NORTH AMERICA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 94 NORTH AMERICA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 95 NORTH AMERICA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 96 NORTH AMERICA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 97 NORTH AMERICA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 98 NORTH AMERICA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 99 U.S. LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 100 U.S. CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 101 U.S. CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 102 U.S. LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 103 U.S. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 104 U.S. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 105 U.S. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 106 U.S. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 107 U.S. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 108 U.S. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 109 U.S. ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 110 U.S. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 111 U.S. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 112 U.S. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 113 U.S. SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 114 U.S. LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 115 U.S. CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 116 U.S. CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 117 U.S. CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 118 U.S. EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 119 U.S. EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 120 U.S. LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 121 U.S. LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 122 U.S. MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 123 U.S. PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 124 U.S. LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 125 U.S. CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 126 U.S. BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 127 U.S. NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 128 U.S. LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 129 U.S. TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 130 U.S. LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 131 U.S. LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 132 U.S. LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 133 CANADA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 134 CANADA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 135 CANADA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 136 CANADA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 137 CANADA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 138 CANADA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 139 CANADA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 140 CANADA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 141 CANADA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 142 CANADA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 143 CANADA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 144 CANADA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 145 CANADA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 146 CANADA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 147 CANADA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 148 CANADA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 149 CANADA CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 150 CANADA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 151 CANADA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 152 CANADA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 153 CANADA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 154 CANADA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 155 CANADA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 156 CANADA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 157 CANADA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 158 CANADA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 159 CANADA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 160 CANADA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 161 CANADA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 162 CANADA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 163 CANADA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 164 CANADA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 165 CANADA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 166 CANADA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 167 MEXICO LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 168 MEXICO CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 169 MEXICO CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 170 MEXICO LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 171 MEXICO TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 172 MEXICO TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 173 MEXICO TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 174 MEXICO COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 175 MEXICO COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 176 MEXICO COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 177 MEXICO ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 178 MEXICO INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 179 MEXICO INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 180 MEXICO INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 181 MEXICO SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 182 MEXICO LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 183 MEXICO CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 184 MEXICO CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 185 MEXICO CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 186 MEXICO EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 187 MEXICO EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 188 MEXICO LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 189 MEXICO LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 190 MEXICO MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 191 MEXICO PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 192 MEXICO LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 193 MEXICO CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 194 MEXICO BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 195 MEXICO NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 196 MEXICO LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 197 MEXICO TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 198 MEXICO LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 199 MEXICO LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 200 MEXICO LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 201 EUROPE LIQUID BIOPSY MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 202 EUROPE LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 203 EUROPE CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 204 EUROPE CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 205 EUROPE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 206 EUROPE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 207 EUROPE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 208 EUROPE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 209 EUROPE ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 210 EUROPE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 211 EUROPE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 212 EUROPE SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 213 EUROPE LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 214 EUROPE CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 215 EUROPE CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 216 EUROPE CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 217 EUROPE EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 218 EUROPE EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 219 EUROPE LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 220 EUROPE LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 221 EUROPE MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 222 EUROPE PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 223 EUROPE LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 224 EUROPE CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 225 EUROPE BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 226 EUROPE NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 227 EUROPE LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 228 EUROPE TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 229 EUROPE LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 230 EUROPE LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 231 EUROPE LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 232 GERMANY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 233 GERMANY CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 234 GERMANY CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 235 GERMANY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 236 GERMANY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 237 GERMANY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 238 GERMANY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 239 GERMANY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 240 GERMANY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 241 GERMANY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)

TABLE 242 GERMANY ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 243 GERMANY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 244 GERMANY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 245 GERMANY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 246 GERMANY SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 247 GERMANY LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 248 GERMANY CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 249 GERMANY CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 250 GERMANY CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 251 GERMANY EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 252 GERMANY EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 253 GERMANY LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 254 GERMANY LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 255 GERMANY MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 256 GERMANY PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 257 GERMANY LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 258 GERMANY CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 259 GERMANY BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 260 GERMANY NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 261 GERMANY LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 262 GERMANY TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 263 GERMANY LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 264 GERMANY LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 265 GERMANY LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 266 FRANCE LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 267 FRANCE CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 268 FRANCE CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 269 FRANCE LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 270 FRANCE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 271 FRANCE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 272 FRANCE TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 273 FRANCE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 274 FRANCE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 275 FRANCE COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 276 FRANCE ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 277 FRANCE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 278 FRANCE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 279 FRANCE INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 280 FRANCE SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 281 FRANCE LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 282 FRANCE CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 283 FRANCE CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 284 FRANCE CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 285 FRANCE EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 286 FRANCE EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 287 FRANCE LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 288 FRANCE LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 289 FRANCE MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 290 FRANCE PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 291 FRANCE LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 292 FRANCE CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 293 FRANCE BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 294 FRANCE NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 295 FRANCE LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 296 FRANCE TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 297 FRANCE LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 298 FRANCE LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 299 FRANCE LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 300 U.K. LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 301 U.K. CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 302 U.K. CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 303 U.K. LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 304 U.K. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 305 U.K. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 306 U.K. TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 307 U.K. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 308 U.K. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 309 U.K. COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 310 U.K. ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 311 U.K. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 312 U.K. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 313 U.K. INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 314 U.K. SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 315 U.K. LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 316 U.K. CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 317 U.K. CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 318 U.K. CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 319 U.K. EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 320 U.K. EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 321 U.K. LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 322 U.K. LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 323 U.K. MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 324 U.K. PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 325 U.K. LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 326 U.K. CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 327 U.K. BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 328 U.K. NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 329 U.K. LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 330 U.K. TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 331 U.K. LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 332 U.K. LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 333 U.K. LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 334 ITALY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 335 ITALY CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 336 ITALY CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 337 ITALY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 338 ITALY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 339 ITALY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 340 ITALY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 341 ITALY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 342 ITALY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 343 ITALY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 344 ITALY ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 345 ITALY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 346 ITALY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 347 ITALY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 348 ITALY SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 349 ITALY LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 350 ITALY CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 351 ITALY CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 352 ITALY CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 353 ITALY EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 354 ITALY EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 355 ITALY LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 356 ITALY LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 357 ITALY MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 358 ITALY PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 359 ITALY LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 360 ITALY CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 361 ITALY BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 362 ITALY NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 363 ITALY LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 364 ITALY TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 365 ITALY LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 366 ITALY LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 367 ITALY LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 368 SPAIN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 369 SPAIN CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 370 SPAIN CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 371 SPAIN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 372 SPAIN TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 373 SPAIN TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 374 SPAIN TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 375 SPAIN COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 376 SPAIN COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 377 SPAIN COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 378 SPAIN ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 379 SPAIN INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 380 SPAIN INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 381 SPAIN INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 382 SPAIN SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 383 SPAIN LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 384 SPAIN CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 385 SPAIN CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 386 SPAIN CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 387 SPAIN EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 388 SPAIN EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 389 SPAIN LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 390 SPAIN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 391 SPAIN MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 392 SPAIN PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 393 SPAIN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 394 SPAIN CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 395 SPAIN BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 396 SPAIN NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 397 SPAIN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 398 SPAIN TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 399 SPAIN LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 400 SPAIN LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 401 SPAIN LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 402 RUSSIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 403 RUSSIA CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 404 RUSSIA CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 405 RUSSIA LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 406 RUSSIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 407 RUSSIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 408 RUSSIA TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 409 RUSSIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 410 RUSSIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 411 RUSSIA COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (ASP)
TABLE 412 RUSSIA ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 413 RUSSIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 414 RUSSIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 415 RUSSIA INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 416 RUSSIA SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 417 RUSSIA LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 418 RUSSIA CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 419 RUSSIA CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 420 RUSSIA CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 421 RUSSIA EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 422 RUSSIA EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 423 RUSSIA LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 424 RUSSIA LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 425 RUSSIA MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 426 RUSSIA PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 427 RUSSIA LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 428 RUSSIA CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 429 RUSSIA BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 430 RUSSIA NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 431 RUSSIA LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 432 RUSSIA TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 433 RUSSIA LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 434 RUSSIA LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 435 RUSSIA LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 436 TURKEY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 437 TURKEY CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 438 TURKEY CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 439 TURKEY LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 440 TURKEY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 441 TURKEY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 442 TURKEY TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 443 TURKEY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 444 TURKEY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 445 TURKEY COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 446 TURKEY ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 447 TURKEY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 448 TURKEY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 449 TURKEY INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 450 TURKEY SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 451 TURKEY LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 452 TURKEY CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 453 TURKEY CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 454 TURKEY CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 455 TURKEY EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 456 TURKEY EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 457 TURKEY LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)
TABLE 458 TURKEY LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 459 TURKEY MOLECULAR IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 460 TURKEY PROTEOMIC IN LIQUID BIOPSY MARKET, BY ANALYTICAL TYPE, 2022-2031 (USD MILLION)
TABLE 461 TURKEY LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 462 TURKEY CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 463 TURKEY BREAST IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 464 TURKEY NON-CANCER APPLICATIONS IN LIQUID BIOPSY MARKET, BY APPLICATION TYPE, 2022-2031 (USD MILLION)
TABLE 465 TURKEY LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 466 TURKEY TREATMENT MONITORING IN LIQUID BIOPSY MARKET, BY CLINICAL APPLICATION, 2022-2031 (USD MILLION)
TABLE 467 TURKEY LIQUID BIOPSY MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)
TABLE 468 TURKEY LIQUID BIOPSY MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 469 TURKEY LIQUID BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 470 BELGIUM LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 471 BELGIUM CONSUMABLES & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 472 BELGIUM CONSUMABLE & ACCESSORIES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 473 BELGIUM LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 474 BELGIUM TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 475 BELGIUM TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 476 BELGIUM TEST KITS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 477 BELGIUM COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 478 BELGIUM COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 479 BELGIUM COLLECTION TUBES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031, (ASP)
TABLE 480 BELGIUM ASSAYS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 481 BELGIUM INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 482 BELGIUM INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (UNITS)
TABLE 483 BELGIUM INSTRUMENTS IN LIQUID BIOPSY MARKET, BY PRODUCTS, 2022-2031, (ASP)
TABLE 484 BELGIUM SERVICES & SOFTWARE IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 485 BELGIUM LIQUID BIOPSY MARKET, BY BIOMAKER TYPE, 2022-2031 (USD MILLION)
TABLE 486 BELGIUM CIRCULATING TUMOR CELLS (CTC'S) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 487 BELGIUM CIRCULATING CELL-FREE DNA (CFDNA) IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 488 BELGIUM CELL-FREE RNA IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 489 BELGIUM EXOSOMES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 490 BELGIUM EXTRACELLULAR VESICLES IN LIQUID BIOPSY MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 491 BELGIUM LIQUID BIOPSY MARKET, BY SAMPLE TYPE, 2022-2031 (USD MILLION)

LIST OF FIGURES

FIGURE 1 GLOBAL LIQUID BIOPSY MARKET: SEGMENTATION
FIGURE 2 GLOBAL LIQUID BIOPSY MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL LIQUID BIOPSY MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL LIQUID BIOPSY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL LIQUID BIOPSY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL LIQUID BIOPSY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL LIQUID BIOPSY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL LIQUID BIOPSY MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 9 GLOBAL LIQUID BIOPSY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL LIQUID BIOPSY MARKET: SEGMENTATION
FIGURE 11 THE ADVANCEMENTS IN PRECISION MEDICINE DUE TO LIQUID BIOPSY IS EXPECTED TO DRIVE THE GLOBAL LIQUID BIOPSY MARKET GROWTH IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 12 CONSUMABLES & ACCESSORIES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL LIQUID BIOPSY MARKET IN 2024 AND 2031
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL LIQUID BIOPSY MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD 2024 TO 2031
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL LIQUID BIOPSY MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL LIQUID BIOPSY MARKET
FIGURE 16 ADVANTAGES OF LIQUID BIOPSY OVER TRADITIONAL BIOPSY
FIGURE 17 GLOBAL LIQUID BIOPSY MARKET: BY PRODUCT, 2023
FIGURE 18 GLOBAL LIQUID BIOPSY MARKET: BY PRODUCT, 2024-2031 (USD MILLION)
FIGURE 19 GLOBAL LIQUID BIOPSY MARKET: BY PRODUCT, CAGR (2024-2031)
FIGURE 20 GLOBAL LIQUID BIOPSY MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 21 GLOBAL LIQUID BIOPSY MARKET: BY BIOMAKER TYPE, 2023
FIGURE 22 GLOBAL LIQUID BIOPSY MARKET: BY BIOMAKER TYPE, 2024-2031 (USD MILLION)
FIGURE 23 GLOBAL LIQUID BIOPSY MARKET: BY BIOMAKER TYPE, CAGR (2024-2031)
FIGURE 24 GLOBAL LIQUID BIOPSY MARKET: BY BIOMAKER TYPE, LIFELINE CURVE
FIGURE 25 GLOBAL LIQUID BIOPSY MARKET: BY SAMPLE TYPE, 2023
FIGURE 26 GLOBAL LIQUID BIOPSY MARKET: BY SAMPLE TYPE, 2024-2031 (USD MILLION)
FIGURE 27 GLOBAL LIQUID BIOPSY MARKET: BY SAMPLE TYPE, CAGR (2024-2031)
FIGURE 28 GLOBAL LIQUID BIOPSY MARKET: BY SAMPLE TYPE, LIFELINE CURVE
FIGURE 29 GLOBAL LIQUID BIOPSY MARKET: BY ANALYTICAL TYPE, 2023
FIGURE 30 GLOBAL LIQUID BIOPSY MARKET: BY ANALYTICAL TYPE, 2024-2031 (USD MILLION)
FIGURE 31 GLOBAL LIQUID BIOPSY MARKET: BY ANALYTICAL TYPE, CAGR (2024-2031)
FIGURE 32 GLOBAL LIQUID BIOPSY MARKET: BY ANALYTICAL TYPE, LIFELINE CURVE
FIGURE 33 GLOBAL LIQUID BIOPSY MARKET: BY APPLICATION TYPE, 2023
FIGURE 34 GLOBAL LIQUID BIOPSY MARKET: BY APPLICATION TYPE, 2024-2031 (USD MILLION)
FIGURE 35 GLOBAL LIQUID BIOPSY MARKET: BY APPLICATION TYPE, CAGR (2024-2031)
FIGURE 36 GLOBAL LIQUID BIOPSY MARKET: BY APPLICATION TYPE, LIFELINE CURVE
FIGURE 37 GLOBAL LIQUID BIOPSY MARKET: BY CLINICAL APPLICATION, 2023
FIGURE 38 GLOBAL LIQUID BIOPSY MARKET: BY CLINICAL APPLICATION, 2024-2031 (USD MILLION)
FIGURE 39 GLOBAL LIQUID BIOPSY MARKET: BY CLINICAL APPLICATION, CAGR (2024-2031)
FIGURE 40 GLOBAL LIQUID BIOPSY MARKET: BY CLINICAL APPLICATION, LIFELINE CURVE
FIGURE 41 GLOBAL LIQUID BIOPSY MARKET: BY TECHNOLOGY, 2023
FIGURE 42 GLOBAL LIQUID BIOPSY MARKET: BY TECHNOLOGY, 2024-2031 (USD MILLION)
FIGURE 43 GLOBAL LIQUID BIOPSY MARKET: BY TECHNOLOGY, CAGR (2024-2031)
FIGURE 44 GLOBAL LIQUID BIOPSY MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 45 GLOBAL LIQUID BIOPSY MARKET: BY END USER, 2023
FIGURE 46 GLOBAL LIQUID BIOPSY MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 47 GLOBAL LIQUID BIOPSY MARKET: BY END USER, CAGR (2024-2031)
FIGURE 48 GLOBAL LIQUID BIOPSY MARKET: BY END USER, LIFELINE CURVE
FIGURE 49 GLOBAL LIQUID BIOPSY MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 50 GLOBAL LIQUID BIOPSY MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 51 GLOBAL LIQUID BIOPSY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 52 GLOBAL LIQUID BIOPSY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 53 GLOBAL LIQUID BIOPSY MARKET: SNAPSHOT (2023)
FIGURE 54 GLOBAL LIQUID BIOPSY MARKET: COMPANY SHARE 2023 (%)
FIGURE 55 NORTH AMERICA LIQUID BIOPSY MARKET: COMPANY SHARE 2023 (%)
FIGURE 56 EUROPE LIQUID BIOPSY MARKET: COMPANY SHARE 2023 (%)
FIGURE 57 ASIA-PACIFIC LIQUID BIOPSY MARKET: COMPANY SHARE 2023 (%)
FIGURE 58 CONSUMABLES AND ACCESSORIES: COMPANY SHARE ANALYSIS 2023 (%)
FIGURE 59 INSTRUMENTS: COMPANY SHARE ANALYSIS 2023 (%)
FIGURE 60 SOFTWARES AND SERVICES: COMPANY SHARE ANALYSIS 2023 (%)